ArticleCancer chemotherapy and pharmacology2019

Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies.

Leonard J Appleman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.